2014•Critical CareOpen access

Vasopressin versus norepinephrine for the management of septic shock in cancer patients

Cristiane Maciel Zambolim, D Nagaoka, J Fukushima, C Park, Juliana Saran Carneiro, E Osawa, Juliano Pinheiro de Almeida, S Zefferino, F Galas, Ludhmila Abrahão Hajjar

Open full text 4 citations

Abstract

Patients with septic shock die mainly due to refractory shock. Vasopressin is commonly used as an adjunct to catecholamines to support blood pressure in refractory septic shock, but its effect on mortality is unknown. We hypothesized that vasopressin as compared with norepinephrine would decrease mortality among cancer patients with septic shock.

Open-access reader

About this research paper

What this paper is about

Why it matters

OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Vasopressin, Septic shock, Medicine, Norepinephrine, Refractory (planetary science), Shock (circulatory), Blood pressure, Cancer